Skip to main content

Advertisement

SpringerLink
Log in

Angiogenesis treatment, new concepts on the horizon

  • Meeting Report
  • Published:
Angiogenesis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182–1186

    Article  PubMed  CAS  Google Scholar 

  2. Dvorak HF, Orenstein NS, Carvalho AC, et al (1979) Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J Immunol 122:166–174

    PubMed  CAS  Google Scholar 

  3. Teicher BA, Sotomayor EA, and Huang ZD (1992) Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 52:6702–6704

    PubMed  CAS  Google Scholar 

  4. Winkler F, Kozin SV, Tong RT, et al (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6:553–563

    PubMed  CAS  Google Scholar 

  5. Willett CG, Boucher Y, di Tomaso E, et al (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10:145–147

    Article  PubMed  CAS  Google Scholar 

  6. Tong RT, Boucher Y, Kozin SV, et al (2004) Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 64:3731–3736

    Article  PubMed  CAS  Google Scholar 

  7. Crane CH, Ellis LM, Abbruzzese JL, et al (2006) Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol 24:1145–1151

    Article  PubMed  CAS  Google Scholar 

  8. Willett CG, Boucher Y, Duda DG, et al (2005) Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol 23:8136–8139

    Article  PubMed  Google Scholar 

  9. Jain RK (2001) Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7:987–989

    Article  PubMed  CAS  Google Scholar 

  10. Ansiaux R, Baudelet C, Jordan BF, et al (2005) Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clin Cancer Res 11:743–750

    PubMed  CAS  Google Scholar 

  11. Kamba T, Tam BY, Hashizume H, et al (2006) VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 290:H560–576

    Article  PubMed  CAS  Google Scholar 

  12. Shaked Y, Bocci G, Munoz R, et al (2005) Cellular and molecular surrogate markers to monitor targeted and non-targeted antiangiogenic drug activity and determine optimal biologic dose. Curr Cancer Drug Targets 5:551–559

    Article  PubMed  CAS  Google Scholar 

  13. Rehman S, Jayson GC (2005) Molecular imaging of antiangiogenic agents. Oncologist 10:92–103

    Article  PubMed  CAS  Google Scholar 

  14. Kerbel RS (1997) A cancer therapy resistant to resistance. Nature 390:335–336

    Article  PubMed  CAS  Google Scholar 

  15. Hida K, Hida Y, Amin DN, et al (2004) Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res 64:8249–8255

    Article  PubMed  CAS  Google Scholar 

  16. Lee NV, Rodriguez-Manzaneque JC, Thai SN, et al (2005) Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1. J Biol Chem 280:34796–34804

    Article  PubMed  CAS  Google Scholar 

  17. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867

    Article  PubMed  CAS  Google Scholar 

  18. Stiver SI, Tan X, Brown LF, et al (2004) VEGF-A angiogenesis induces a stable neovasculature in adult murine brain. J Neuropathol Exp Neurol 63:841–855

    PubMed  CAS  Google Scholar 

  19. Weis SM, Cheresh DA (2005) Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437:497–504

    Article  PubMed  CAS  Google Scholar 

  20. Bergers G, Song S (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro-oncol 7:452–464

    Article  PubMed  CAS  Google Scholar 

  21. Kaplan RN, Riba RD, Zacharoulis S, et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820–827

    Article  PubMed  CAS  Google Scholar 

  22. Chen K, Dockser Marcus A (2005) Once-touted drug for cancer finds new life in China. In The Wall Street Journal. Boston. A1–6

  23. Aird WC (2006) Mechanisms of endothelial cell heterogeneity in health and disease. Circ Res 98:159–162

    Article  PubMed  CAS  Google Scholar 

  24. Kuldo JM, Ogawara KI, Werner N, et al (2005) Molecular pathways of endothelial cell activation for (targeted) pharmacological intervention of chronic inflammatory diseases. Curr Vasc Pharmacol 3:11–39

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Therapeutic Radiology-Radiation Oncology, University of Minnesota, Minneapolis, 55455, MN, USA

    Robert J. Griffin & Ruud P.M. Dings

  2. Department of Pathology and Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

    Grietje Molema

  3. Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, 312 Church Street, Hasselmo Hall, Office 5-258, Minneapolis, 55455, MN, USA

    Ruud P.M. Dings

Authors
  1. Robert J. Griffin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Grietje Molema
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ruud P.M. Dings
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ruud P.M. Dings.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Griffin, R.J., Molema, G. & Dings, R.P. Angiogenesis treatment, new concepts on the horizon. Angiogenesis 9, 67–72 (2006). https://doi.org/10.1007/s10456-006-9031-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10456-006-9031-3

Keywords

Search

Navigation